Domov › Rakovina endometria › Minnesota › Minneapolis
Klinické štúdie Rakovina endometria v meste Minneapolis, MN
18 štúdií pre Rakovina endometria hľadá účastníkov v zariadeniach v meste Minneapolis a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Prebieha náborFáza 3
- Abbott-Northwestern Hospital, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 míľ odtiaľ
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Prebieha náborFáza 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 míľ odtiaľ
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · 5 míľ odtiaľ
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Prebieha náborFáza 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 míľ odtiaľ
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Prebieha náborFáza 3
- Minnesota Oncology Hematology, PA ( Site 8003), Minneapolis
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Prebieha náborFáza 3
- USOR - Minnesota Oncology/ Minneapolis Clinic, Minneapolis
- USOR - Minnesota Oncology, Minneapolis
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Prebieha náborFáza 3
- Research Site, Minneapolis
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- University of Minnesota Masonic Cancer Center, Minneapolis
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Prebieha náborFáza 1
- University of Minnesota, Minneapolis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Prebieha náborFáza 1/2
- University of Minnesota/Masonic Cancer Center, Minneapolis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Prebieha náborFáza 1
- Normunity Investigational Site, Minneapolis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Prebieha náborFáza 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Prebieha náborFáza 3
- Research Site, Minneapolis
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Prebieha náborFáza 2
- 518, Minneapolis
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Prebieha náborFáza 1
- University of Minnesota, Minneapolis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Allina Health Cancer Institute, Minneapolis
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Prebieha náborFáza 2/3
- Minnesota Oncology Hematology, P.A., Minneapolis
Štúdie Rakovina endometria v iných mestách
- Houston, TX68 štúdií
- New York City, NY52 štúdií
- Boston, MA50 štúdií
- Arlington, VA39 štúdií
- Nashville, TN38 štúdií
- Los Angeles, CA34 štúdií
- St. Louis, MO29 štúdií
- Philadelphia, PA28 štúdií
- San Antonio, TX27 štúdií
- Columbus, OH25 štúdií
- Oklahoma City, OK25 štúdií
- Chicago, IL25 štúdií
Iné štúdie v Minneapolis
- Nemalobunkový karcinóm pľúc27 štúdií
- Rakovina prsníka27 štúdií
- Rakovina vaječníkov24 štúdií
- Rakovina prostaty23 štúdií
- Rakovina (všetky typy)22 štúdií
- Srdcové zlyhanie21 štúdií
- Akútna myeloidná leukémia20 štúdií
- Rakovina pľúc20 štúdií
- Kolorektálny karcinóm19 štúdií
- Parkinsonova choroba17 štúdií
- Kardiovaskulárne ochorenia15 štúdií
- Koronárne ochorenie srdca13 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.